MEKTOVI ® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Conditions: Adamantinous Craniopharyngioma; Recurrent Adamantinomatous Craniopharyngioma Intervention: Drug: Binimetinib Oral Tablet [Mektovi] Sponsors: Nationwide Children's Hospital; Children's Hospital Colorado Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials